In vitro study of mediators of inflammation in multiple sclerosis

Journal of Clinical Immunology

Volumn 9, Issue 2, 1989, Pages 84-96

  Merrill, Jean E ^a   Strom, Sheila R ^a   Ellison, George W ^a   Myers, Lawrence W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammatory mediators; interleukin 1; macrophages; Multiple sclerosis; tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; LEUKOTRIENE B4; PROSTAGLANDIN E; TUMOR NECROSIS FACTOR;

CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; FEMALE; HUMAN; INFLAMMATION; INTERLEUKIN-1; LEUKOTRIENE B4; MACROPHAGES; MALE; MULTIPLE SCLEROSIS; NEUROMUSCULAR DISEASES; PROSTAGLANDINS E; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0024522245     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/BF00916935     Document Type: Article

References (57)

1. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
2. Immunoregulatory molecules and IL2 receptors identified in multiple sclerosis brain
3. Prostaglandin release in multiple sclerosis: Correlation with disease activity
4. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. 1. Association between the amount of prostaglandin produced, natural killer, and endogenous interferon
5. Biology of disease: Free radicals and tissue injury
6. Multiple sclerosis patients show an increased spontaneous activity of their peripheral blood monocytes as measured by chemillu-minescence
7. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients
8. Lymphokines and the brain
9. Pyrogen, fever, and prostaglandin-like activity in cerebrospinal fluid
10. Is prostaglandin E2 involved in the pathogenesis of fever? Effects of interleukin 1 on the release of prostaglandins
11. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of Interleukin 1
12. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, interferon, and interleukin 1
13. Production of cytotoxic factors for oligoden-drocytes by stimulated astrocytes
14. Clinicopathological correlations in multiple sclerosis and related diseases
15. Modes of action of aspirin-like drugs
16. Problems of experimental trials of therapy in multiple sclerosis
17. Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes
18. Rapid identification of monocytes in a mixed mononuclear cell preparations
19. Specificites of prostaglandins B, F1, and F2 antigen-antibody reactions
20. A radioimmunoassay for leukotriene B4
21. Human tumor necrosis factor: Production, purification, and characterization
22. A rapid biologic assay for the detection of interleukin 1
23. T cell growth factor: Parameters of production and a quantitative microassay for activity
24. Piroxicam, a potent inhibitor of prostaglandin production
25. Cerebrospinal fluid interleukin 1-like activity during chronic relapsing experimental allergic encephalomyelitis
26. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats
27. Differential effects of interferon and interferon on interleukin 1 secretion by monocytes
28. Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: Analysis at the single cell level of the relationship of cytotoxic effectors and interferon-producing cells
29. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro
30. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system
31. Tumor necrosis factor mediates myelin and oligodendrocytes damage in vitro
32. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis
33. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. 2. Effect of exogenous PGE on spontaneous and interferon-induced natural killer
34. The role of prostaglandins in altered leukocyte function in multiple sclerosis
35. Leukotrienes increase blood brain barrier permeability following intraparenchymal injections in rats
36. Calcium ionophore does not stimulate lipopolysaccharide nonresponsive C3H/HeJ peritoneal macrophages to produce Interleukin 1
37. Effects of soluble stimulation on human monocyte secretion
38. Protein kinase C mediates endotoxin and zymosan-induced prostaglandin synthesis
39. Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5,bisphosphate in murine peritoneal macrophages
40. Effects of immune complexes on production by human monocytes of interleukin 1 or and interleukin 1 inhibitor
41. Macrophage dependent activation of helper T cells. I. Production of interleukin 2
42. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vitro and in human mononuclear cells in vitro
43. Prostaglandins postranscriptionally inhibit monocyte expressions of interleukin 1 activity by increasing intracellular cycline adenosine monophosphate
44. Dynamics and regulation of murine tumor necrosis factor (TNF) and interleukin 1 (IL-1) gene expression by arachidonate metabolites
45. Studies of an interleukin 1 inhibitor: Characterization and clinical significance
46. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA
47. Prostaglandin E inhibits the production of human interleukin 2
48. Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods
49. Differential ability of human blood monocyte subsets to release various cytokines
50. Tumor necrosis factor in cerebrospinal fluid during bacterial, but not viral, meningitis
51. Current concepts in immunology: Monocytes and macrophages
52. Leukotrienes B4 and C4 in MS
53. Leukotrienes augment interleukin 1 production by human monocytes
54. prostaglandins as endogenous mediators of interleukin 1 production
55. Effect of diclofenac sodium on the arachidonic acid cascade